Insmed | INSM - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
DBV Technologies USD 58.02M 8.54M 2025-12
Gilead Sciences USD 9.48B 2.34B 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Insmed USD 361.01M 107.87M 2026-03
Novartis USD 27.28B 4.72B 2025-12
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03